Schedule 13G ownership disclosure

REVELATION BIOSCIENCES, INC.

Common Stock, par value $0.001 per share · CUSIP: 76135L101

Event date: 2023-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • AXA IM Prime Impact Master Fund I SCA SICAV-RAIF

    Shares: 55,971.00 · Class: 0.9%

  • AXA IM Prime Impact GP S.a.r.l

    Shares: 55,971.00 · Class: 0.9%

  • AXA Investment Managers Paris

    Shares: 55,971.00 · Class: 0.9%

  • AXA INVESTMENT MANAGERS UK Ltd

    Shares: 55,971.00 · Class: 0.9%

  • AXA Investment Managers S.A.

    Shares: 55,971.00 · Class: 0.9%

  • AXA S.A.

    Shares: 55,971.00 · Class: 0.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001884552-24-000001
Form type
SCHEDULE 13G/A
Filer
AXA IM Prime Impact Master Fund I SCA SICAV-RAIF
CIK
CIK 1884552
Filed
Feb 12, 2024
Reporting period
Dec 31, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub